Vitae Pharmaceuticals Inc (VTAE)

Currency in USD
21.00
0.00(0.00%)
Closed·
Showing Vitae Pharmaceuticals Inc historical data. For real-time data please try another search
Day's Range
20.9921.00
52 wk Range
0.0021.00
Key Statistics
Prev. Close
21
Open
20.99
Day's Range
20.99-21
52 wk Range
0-0
Volume
-
Average Volume (3m)
1.28M
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Vitae Pharmaceuticals Inc Company Profile

Vitae Pharmaceuticals, Inc., a biotechnology company, focuses on discovering and developing novel and small molecule drugs for diseases with unmet medical needs in the United States. Its products include VTP-43742 in Phase I clinical trial for the treatment of autoimmune disorders, including psoriasis, psoriatic arthritis, ankylosing spondylitis, inflammatory bowel disease, and multiple sclerosis; VTP-38543 in Phase IIa for the treatment of atopic dermatitis; and BI 1147560 for the treatment and prevention of Alzheimer's disease. The company’s products also include VTP-34072 that is in Phase II clinical trial for the treatment of type 2 diabetes; and VTP-38443 for the treatment of acute coronary syndrome. Vitae Pharmaceuticals, Inc. was formerly known as Concurrent Pharmaceuticals, Inc. and changed its name to Vitae Pharmaceuticals, Inc. in January 2005. The company was founded in 2001 and is headquartered in Fort Washington, Pennsylvania. Vitae Pharmaceuticals, Inc. operates as a subsidiary of AbbVie Inc.

Earnings

Latest Release
Mar 08, 2019
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

VTAE Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.